# Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease

> **NCT01696708** · NA · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 50 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **OTHER:** 31-Phosphorus RMN Spectroscopy

## Key facts

- **NCT ID:** NCT01696708
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-06
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01696708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01696708, "Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01696708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*